Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Quality, Reproducibility, and Integrity in Early Research

Posted on November 30th, 2016 by in Pharma R&D

It is sad to hear about more paper retractions regarding early stage research with the R&D industry (1). Perhaps not surprisingly, the number of scientific publications being retracted for fraud and error has increased in recent years, at a faster rate than the rate of increased publications (2). Continue reading “Quality, Reproducibility, and Integrity in Early Research” »